Drug repurposing against COVID-19: focus on anticancer agents.

Gennaro CilibertoRita ManciniMarco G Paggi

Published in: Journal of experimental & clinical cancer research : CR (2020)

To our knowledge, cancer drugs potentially suitable for facing SARS-CoV-2 infection have not been carefully reviewed. We present here a comprehensive analysis of available information on potential candidate cancer drugs that can be repurposed for the treatment of COIVD-19.

Keyphrases

papillary thyroid
squamous cell
coronavirus disease
sars cov
healthcare
emergency department
lymph node metastasis
risk assessment